Article
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Pediatric blood & cancer - 1 Dec 2020
Hasegawa Daiichiro, Tawa Akio, Tomizawa Daisuke, Watanabe Tomoyuki, Saito Akiko Moriya, Kudo Kazuko, Taga Takashi, Iwamoto Shotaro, Shimada Akira, Terui Kiminori, Moritake Hiroshi, Kinoshita Akitoshi, Takahashi Hiroyuki, Nakayama Hideki, Koh Katsuyoshi, Goto Hiroaki, Kosaka Yoshiyuki, Miyachi Hayato, Horibe Keizo, Nakahata Tatsutoshi, Adachi Souichi
Abstract excerpt
We previously reported that risk-stratified therapy and intensive postremission chemotherapy (PRC) contributed to the improved survival of childhood acute myeloid leukemia (AML) in the AML99 study, which led us to consider a reduction in the number of PRC courses with more restrictive indications for stem cell transplantation (SCT) in the successor AML-05 study. We here report the outcome of AML patients without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
